Evaluation of cancer trial eligibility criteria (with focus on non-AIDS–defining cancers) for inclusion of persons with HIV infection.

6092 Background: Non-AIDS-defining cancers (NADC) have become a significant cause of mortality in persons with HIV-infection. In 2008, the Cancer Therapy Evaluation Program (CTEP) set guidelines th...